Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells

Mazurek, Sybille·2011·The International Journal of Biochemistry & Cell Biology
DOI 10.1016/j.biocel.2010.02.005

Cited by (707)

Items 201–300 of 707

  1. Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms
    Kohei Taniguchi, Yuko Ito, Nobuhiko Sugito, Minami Kumazaki, Haruka Shinohara, Nami O. Yamada, Yoshihito Nakagawa, Tarou Sugiyama, Manabu Futamura, Yoshinori Otsuki et al. · 2015 · Scientific Reports
  2. Vitamin K3 and K5 are inhibitors of tumor pyruvate kinase M2
    Jing Chen, Zheng Jiang, Beibei Wang, Yanguang Wang, Xun Hu · 2011 · Cancer Letters
  3. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis
    Carolin Tonus · 2012 · World Journal of Gastroenterology
  4. GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic culture of human embryonic stem cells
    David R. Christensen, Philip C. Calder, Franchesca D. Houghton · 2015 · Scientific Reports
  5. The Glycogen Shunt Maintains Glycolytic Homeostasis and the Warburg Effect in Cancer
    Robert G. Shulman, Douglas L. Rothman · 2017 · Trends in cancer
  6. Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment
    Duncan Howie, Herman Waldmann, Stephen Paul Cobbold · 2014 · Frontiers in Immunology
  7. Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence
    Mona Ghazi Alharbi, Andrew Lai, Shayna Sharma, Priyakshi Kalita‐de Croft, Nihar Godbole, America V. Campos, Dominic Guanzon, Alexis Salas-Burgos, Flavio Carrión, Felipe Andrés Zuñiga et al. · 2021 · Cancers
  8. Activators of PKM2 in Cancer Metabolism
    Steven L. Warner, Kent J. Carpenter, David J. Bearss · 2014 · Future Medicinal Chemistry
  9. M-Type Pyruvate Kinase Isoforms and Lactate Dehydrogenase A in the Mammalian Retina: Metabolic Implications
    Robert James Casson, John P. M. Wood, Guoge Han, Thaksaon Kittipassorn, Daniel J. Peet, Glyn Chidlow · 2016 · Investigative Ophthalmology & Visual Science
  10. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells
    Haili Wu, Zongwei Li, Peng Yang, Lichao Zhang, Yongsheng Fan, Zhuoyu Li · 2014 · Cellular Signalling
  11. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture
    Tianfu Dong, Youde Yan, Hao Chai, Shenglin Chen, Xinkui Xiong, Daoyi Sun, Yue Yu, Lei Deng, Feng Cheng · 2014 · Biomedicine & Pharmacotherapy
  12. Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways
    Chunmei Wang, Salvatore Delogu, Coral Ho, Susie A. Lee, Bing Gui, Lijie Jiang, Sara Ladu, Antonio Cigliano, Frank Dombrowski, Matthias Evert et al. · 2012 · Journal of Hepatology
  13. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered
    Shutao Zheng, Qing Liu, Tao Liu, Xiaomei Lu · 2021 · Journal of Physiology and Biochemistry
  14. Inhibition of tumour cell growth by carnosine: some possible mechanisms
    Alan R. Hipkiss, Frank Gaunitz · 2013 · Amino Acids
  15. Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia
    Lu Wang, Liyuan Yang, Zailin Yang, Yuting Tang, Yao Tao, Qian Zhan, Lei Li, Yipei Jing, Xueke Jiang, Hongjun Jin et al. · 2019 · International Journal of Biological Sciences
  16. Common Responses of Tumors and Wounds to Hypoxia
    Valéry L. Payen, Lucie Brisson, Mark W. Dewhirst, Pierre Sonveaux · 2015 · The Cancer Journal
  17. Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2)
    Andrew D. James, Daniel A. Richardson, In-Whan Oh, Pishyaporn Sritangos, Thomas Attard, Lisa Barrett, Jason I.E. Bruce · 2019 · British Journal of Cancer
  18. Pyruvate Kinase M2 Promotes Prostate Cancer Metastasis Through Regulating ERK1/2-COX-2 Signaling
    Wenjing Guo, Zhishuai Zhang, Guihuan Li, Xiaoju Lai, Ruonan Gu, Wanfu Xu, Hua Chen, Zhe Xing, Liping Chen, Jiabi Qian et al. · 2020 · Frontiers in Oncology
  19. Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
    Andrea Cunha, Patrícia M. A. Silva, Bruno Filipe Carmelino Cardoso Sarmento, Odília Queirós · 2023 · Pharmaceutics
  20. High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
    Lin Yang, Feng Lv, Fangfang Liu, Xiaojing Guo, Yu Fan, Feng Gu, Jun Gu, Li Fu · 2015 · Journal of Cancer
  21. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase
    Inbal Mor, Rodrigo Carlessi, Tslil Ast, Elena Feinstein, Adi Kimchi · 2011 · Oncogene
  22. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2)
    Yong Xu, Xiaohui Liu, Michael Saunders, Scott Pearce, Jason M. Foulks, K. Mark Parnell, Adrianne Clifford, Rebecca N. Nix, Jeremy Bullough, Thomas F. Hendrickson et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
  23. Heterogeneity of glycolysis in cancers and therapeutic opportunities
    Marc O. Warmoes, Jason W. Locasale · 2014 · Biochemical Pharmacology
  24. Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer
    Meghna Talekar, Qijun Ouyang, Michael S. Goldberg, Mansoor M. Amiji · 2015 · Molecular Cancer Therapeutics
  25. Linc RNA ‐p21 suppresses development of human prostate cancer through inhibition of PKM 2
    Xiaohai Wang, Yongzhi Xu, Xingjie Wang, Chenyi Jiang, Sha Han, Kai Dong, Mengjun Shen, Dongliang Xu · 2017 · Cell Proliferation
  26. Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease
    Antonio Macciò, Elisabetta Sanna, Manuela Neri, Sara Oppi, Clelia Madeddu · 2021 · International Journal of Molecular Sciences
  27. The Role of Ovarian Sex Steroids in Metabolic Homeostasis, Obesity, and Postmenopausal Breast Cancer: Molecular Mechanisms and Therapeutic Implications
    Viroj Boonyaratanakornkit, Prangwan Pateetin · 2015 · BioMed Research International
  28. Aberrant role of pyruvate kinase M2 in the regulation of gamma-secretase and memory deficits in Alzheimer’s disease
    Jonghee Han, Junho Hyun, Jaesang Park, Sunmin Jung, Yoonseo Oh, Youbin Kim, Shin-Hyeon Ryu, Seohyun Kim, Eun Il Jeong, Dong‐Gyu Jo et al. · 2021 · Cell Reports
  29. Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison
    Marta Romo-González, Carla Ijurko, Ángel Hernández‐Hernández · 2022 · Frontiers in Immunology
  30. New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds
    Yu Zhang, Bin Liu, Xingyu Wu, Ridong Li, Xianling Ning, Yu Liu, Zhenming Liu, Zemei Ge, Runtao Li, Yuxin Yin · 2015 · Bioorganic & Medicinal Chemistry
  31. Splicing Programs and Cancer
    Sophie Germann, Lise Gratadou, Martin Dutertre, Didier Auboeuf · 2011 · Journal of Nucleic Acids
  32. Noninvasive assessment of mitochondrial organization in three-dimensional tissues reveals changes associated with cancer development
    Joanna F. Xylas, Antonio Varone, Kyle P. Quinn, Dimitra Pouli, Margaret E. McLaughlin-Drubin, Hong-Thao N. Thieu, Maria Garcia-Moliner, Michael D. House, Martin Hunter, Karl Münger et al. · 2014 · International Journal of Cancer
  33. HPV – A different view on Head and Neck Cancer
    C. Wittekindt, S. Wagner, S. J. Sharma, N. Würdemann, Jennifer Knuth, Henrike Reder, J. Klussmann · 2018 · Laryngo-Rhino-Otologie
  34. Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation
    Jamie A. Macpherson, Alina Theisen, Laura Masino, Louise Fets, Paul C. Driscoll, Vesela Encheva, Ambrosius P. Snijders, Stephen R. Martin, Jens Kleinjung, Perdita E. Barran et al. · 2019 · eLife
  35. Pyruvate Kinase M2 Promotes Expression of Proinflammatory Mediators in House Dust Mite–Induced Allergic Airways Disease
    Cheryl van de Wetering, Reem Aboushousha, Allison M. Manuel, Shi Biao Chia, Cuixia Shi Erickson, Maximilian B. MacPherson, Jos L. J. van der Velden, Vikas Anathy, Anne E. Dixon, Charles G. Irvin et al. · 2020 · The Journal of Immunology
  36. Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents
    Bhagyashri Rathod, Shivam Chak, Sagarkumar Patel, Amit Shard · 2021 · RSC Medicinal Chemistry
  37. The Role of Pyruvate Kinase M2 in Cancer Metabolism
    Vivian M. Liu, Matthew G. Vander Heiden · 2015 · Brain Pathology
  38. Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells
    Bei‐Bei Chu, Jiang Wang, Yueying Wang, Guo‐Yu Yang · 2015 · Molecular Medicine Reports
  39. In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2
    Erdem Aslan, Çağlar Güler, Şevki Adem · 2015 · Journal of Enzyme Inhibition and Medicinal Chemistry
  40. Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators
    Chuangxing Guo, Angelica Linton, Mehran Jalaie, Susan E. Kephart, Martha A. Ornelas, Mason Pairish, Samantha E. Greasley, Paul Richardson, Karen A. Maegley, Michael Hickey et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
  41. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer‐specific metabolism
    Takeharu Shiroki, Misa Yokoyama, Nobuhiro Tanuma, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya et al. · 2017 · Cancer Science
  42. PKM2 and HIF-1α regulation in prostate cancer cell lines
    Diya Hasan, Elisabetta Gamen, Nafez Abu Tarboush, Y. Hussein Mohamed Ismail, Oleg Pak, Belal Azab · 2018 · PLoS ONE
  43. Glutathione-S-transferase P promotes glycolysis in asthma in association with oxidation of pyruvate kinase M2
    Cheryl van de Wetering, Allison M. Manuel, Mona Sharafi, Reem Aboushousha, Xi Qian, Cuixia Shi Erickson, Maximilian B. MacPherson, Garrett J. Chan, Ian Michael Adcock, Nazanin Zounemat Kermani et al. · 2021 · Redox Biology
  44. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2
    Sahil Arora, Gaurav Joshi, Anuhar Chaturvedi, Michael Heuser, Santoshkumar N. Patil, Raj Kumar · 2021 · Journal of Medicinal Chemistry
  45. Mitoplasticity: Adaptation Biology of the Mitochondrion to the Cellular Redox State in Physiology and Carcinogenesis
    Caroline José, Su Melser, Giovanni Bénard, Rodrigue Rossignol · 2012 · Antioxidants and Redox Signaling
  46. Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices
    Ahmed A. Almousa, Marc W Morris, Sharyle A. Fowler, Jennifer Jones, Jane Alcorn · 2017 · Clinical Biochemistry
  47. PHGDH as a mechanism for resistance in metabolically-driven cancers
    Richa Rathore, Charles R. Schutt, Brian Andrew Van Tine · 2020 · Cancer Drug Resistance
  48. Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2
    Rong‐Hsuan Wang, Pin‐Ru Chen, Yue-Ting Chen, Yi‐Chang Chen, Yu-Hsin Chu, Chia-Chen Chien, Po-Chen Chien, Shao-Yun Lo, Zhongliang Wang, Min-Chen Tsou et al. · 2024 · Nature Communications
  49. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway
    Shuichi Fukuda, Hiroshi Miyata, Yasuhiro Miyazaki, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori et al. · 2015 · Annals of Surgical Oncology
  50. PKM2: The Thread Linking Energy Metabolism Reprogramming with Epigenetics in Cancer
    Ling Chen, Ying Shi, Shuang Liu, Ya Cao, Xiang Wang, Yongguang Tao · 2014 · International Journal of Molecular Sciences
  51. PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer
    Junfei Li, Zhuanyi Yang, Qiong Zou, Yanchun Yuan, Junfei Li, Lian Liang, G. Zeng, S. Chen · 2013 · Clinical & Translational Oncology
  52. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells
    Prasanta Kumar Dey, Amit B. Kundu, Richa Sachan, Jae Hyeon Park, Mee Young Ahn, Kyungsil Yoon, Jaewon Lee, Nam Deuk Kim, In Su Kim, Byung Mu Lee et al. · 2019 · Cellular Physiology and Biochemistry
  53. Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
    Aastha Arora, Saurabh Pratap Singh, Anant Narayan Bhatt, Sanjay Pandey, Rajat Sandhir, Bilikere Srinivasa Rao Dwarakanath · 2015 · Translational Oncogenomics
  54. Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism
    Byron DeLaBarre, Jonathan Hurov, Giovanni Cianchetta, Stuart Murray, Lenny Dang · 2014 · Chemistry & Biology
  55. Estradiol-17β Upregulates Pyruvate Kinase M2 Expression to Coactivate Estrogen Receptor-α and to Integrate Metabolic Reprogramming With the Mitogenic Response in Endometrial Cells
    Salama A. Salama, Mahmoud Ali Mohammad, Concepcion Diaz‐Arrastia, Marwa Kamel, Gokhan Sami Kilic, Bih T. Ndofor, Mohamed Shebl Abdelbaki, Stefan Theiler · 2014 · The Journal of Clinical Endocrinology & Metabolism
  56. Pyruvate Kinase M2 Regulates Apoptosis of Intestinal Epithelial Cells in Crohn’s Disease
    Qiyun Tang, Qianqian Ji, Weiwei Xia, Li Li, Jian’an Bai, Runzhou Ni, Yongwei Qin · 2014 · Digestive Diseases and Sciences
  57. Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
    Fredy Omar Beltrán‐Anaya, Alberto Cedro‐Tanda, Alfredo Hidalgo‐Miranda, Sandra Lorena Romero-Cordoba · 2016 · Frontiers in Physiology
  58. Targeting metabolic pathways for head and neck cancers therapeutics
    Masashi Yamamoto, Hidenori Inohara, Takashi Nakagawa · 2017 · Cancer and Metastasis Reviews
  59. OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance
    Da‐Yong Hou, Wuyi Xiao, Jiaqi Wang, Yaseen Muhammad, Zhijia Wang, Yue Fei, Man‐Di Wang, Lu Wang, Hui Wang, Xinghua Shi et al. · 2022 · Biomaterials
  60. Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition
    Joseph D. Coppock, Bryant G. Wieking, Alfredo Molinolo, Jorge Silvio Gutkind, W. Keith Miskimins, John H. Lee · 2013 · Neoplasia
  61. Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis
    Jiansheng Xie, Chunyan Dai, Xun Hu · 2016 · Journal of Biological Chemistry
  62. Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma
    Edward B. Sanders, Svenja Diehl · 2015 · Oncoscience
  63. Research progress on the role of PKM2 in the immune response
    Chunyan Liu, Chenchen Liu, Rong Fu · 2022 · Frontiers in Immunology
  64. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery
    Meghna Talekar, Srinivas Reddy Boreddy, Amit Singh, Mansoor M. Amiji · 2014 · Expert Opinion on Biological Therapy
  65. MicroRNA regulation and analytical methods in cancer cell metabolism
    Ling-Fei Zhang, Shuai Jiang, Mo‐Fang Liu · 2017 · Cellular and Molecular Life Sciences
  66. Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability
    Haili Wu, Peng Yang, Wanglai Hu, Yingying Wang, Yangxu Lu, Lichao Zhang, Yongsheng Fan, Hong Xiao, Zhuoyu Li · 2016 · Oncotarget
  67. Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes
    Ravi P. Cholia, Monisha Dhiman, Raj Kumar, Anil Kumar Mantha · 2018 · Metabolic Brain Disease
  68. PKM2 promotes reductive glutamine metabolism
    Liu Miao, Wang Yuanyuan, Ruan Yuxia, Bai Changsen, Qiu Li, Cui Yanfen, Ying Guoguang, Li Binghui · 2018 · Cancer Biology and Medicine
  69. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma
    Cristina Trejo‐Solís, Daniela Silva‐Adaya, Norma Serrano-García, Roxana Magaña-Maldonado, Dolores Jiménez‐Farfán, Elizabeth Ferreira-Guerrero, Arturo Cruz-Salgado, Rosa Angélica Castillo‐Rodríguez · 2023 · International Journal of Molecular Sciences
  70. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer
    Dipok Kumar Dhar, Steven W.M. Olde Damink, James Hallimond Brindley, Andrew Robert Godfrey, Michael Huw Chapman, Neomal S. Sandanayake, Fausto Andreola, Sybille Mazurek, Tayyaba G. Hasan, Massimo Malagó et al. · 2012 · Cancer
  71. Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics
    Yanrong Qian · 2014 · World Journal of Translational Medicine
  72. The role of pyruvate kinase M2 in anticancer therapeutic treatments (Review)
    Qiongli Su, Shengping Luo, Qiuhong Tan, Jun Deng, Sichun Zhou, Mei Peng, Ting Tao, Xiaoping Yang · 2019 · Oncology Letters
  73. Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells
    Takafumi Shima, Kohei Taniguchi, Yoshihisa Tokumaru, Yosuke Inomata, Jun Arima, Sang‐Woong Lee, Kazuaki Takabe, Kazuhiro Yoshida, Kazuhisa Uchiyama · 2021 · Oncology Reports
  74. PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer
    Yang Wang, Hengyao Shu, Yanzhao Qu, Xin Jin, Jia Liu, Wanting Peng, Lihua Wang, Miao Hao, Mingjie Xia, Zhexuan Zhao et al. · 2024 · The EMBO Journal
  75. Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2
    Fumie Tanaka, Shohei Yoshimoto, Kazuhiko Okamura, Tetsuro Ikebe, Shuichi Hashimoto · 2018 · Oncotarget
  76. ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways
    Yehua Shen, Gang Chen, Liping Zhuang, Litao Xu, Junhua Lin, Luming Liu · 2019 · OncoTargets and Therapy
  77. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines
    Unchalee Thonsri, Wunchana Seubwai, Sakda Waraasawapati, Sopit Wongkham, Thidarat Boonmars, Ubon Cha’on, Chaisiri Wongkham · 2020 · Anticancer Research
  78. Defining the Molecular Basis of Tumor Metabolism: a Continuing Challenge Since Warburg’s Discovery
    Ana Carolina Santos de Souza, Giselle Zenker Justo, Daniele Ribeiro de Araújo, Alexandre Donizeti Martins Cavagis · 2011 · Cellular Physiology and Biochemistry
  79. Homocysteine induces energy imbalance in rat skeletal muscle: Is creatine a protector?
    Janaína Kolling, Emilene B. S. Scherer, Cassiana Siebert, Fernanda Hansen, Felipe Vasconcelos Torres, Giselli Scaini, Gabriela Kozuchovski Ferreira, Rodrigo B. de Andrade, Carlos Alberto Gonçalves, Emilio Luiz STRECK et al. · 2012 · Cell Biochemistry and Function
  80. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells
    Parunya Chaiyawat, Daranee Chokchaichamnankit, Kriengsak Lirdprapamongkol, Chantragan Srisomsap, Jisnuson Svasti, Voraratt Champattanachai · 2015 · Oncology Reports
  81. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase
    Avihai Yacovan, Rachel Ozeri, Tzofit Kehat, Sima Mirilashvili, Daniel Sherman, Alexander Aizikovich, Alina Shitrit, Efrat Ben‐Zeev, Nili C. Schutz, Osnat Bohana‐Kashtan et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
  82. RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells
    Michelle L. Wynn, Joel A. Yates, Charles R. Evans, Lauren D. Van Wassenhove, Zhi-Fen Wu, Sydney Bridges, Liwei Bao, Chelsea L. Fournier, Sepideh Ashrafzadeh, Matthew J. Merrins et al. · 2016 · Journal of Biological Chemistry
  83. Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment
    Mohd Rihan, Lakshmi Vineela Nalla, Anil Dharavath, Amit Shard, Kiran Kalia, Amit Khairnar · 2019 · Cancer Microenvironment
  84. Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection
    Abulizi Abudula, Nuermanguli Rouzi, Lixiu Xu, Yun Yang, Axiangu Hasimu · 2019 · Bosnian Journal of Basic Medical Sciences
  85. The oxygen sensor PHD3 limits glycolysis under hypoxia via direct binding to pyruvate kinase
    Nan Chen, Oliver Rinner, Dominika Czernik, Katarzyna J. Nytko, Dan Zheng, Daniel P. Stiehl, Nicola Zamboni, Matthias Gstaiger, Christian Frei · 2011 · Cell Research
  86. Pivotal Role of Pervasive Neoplastic and Stromal Cells Reprogramming in Circulating Tumor Cells Dissemination and Metastatic Colonization
    Didier Meseure, Kinan Drak Alsibai, Andre Nicolas · 2014 · Cancer Microenvironment
  87. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells
    Yi Miao, Meng Lü, Qin Yan, Shuangdi Li, You-Ji Feng · 2016 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · Retracted
  88. Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses
    Jessica F. Walls, Jeffrey J. Subleski, Erika Mariana Palmieri, Marieli Gonzalez-Cotto, Clair M. Gardiner, Daniel W. McVicar, David K. Finlay · 2020 · eLife
  89. Structures of pyruvate kinases display evolutionarily divergent allosteric strategies
    Hugh P. Morgan, Wenhe Zhong, Iain W. McNae, Paul A.M. Michels, Linda A. Fothergill‐Gilmore, Malcolm D. Walkinshaw · 2014 · Royal Society Open Science
  90. Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression
    Mingxiu Guan, Yingna Tong, Minghua Guan, Xiaobin Liu, Meng Wang, Ruifang Niu, Fei Zhang, Dong Dong, Jie Shao, Yunli Zhou · 2018 · Technology in Cancer Research & Treatment
  91. Proteomic analysis of rat serum revealed the effects of chronic sleep deprivation on metabolic, cardiovascular and nervous system
    Bo Ma, Jincheng Chen, Yongying Mu, Bingjie Xue, Aimei Zhao, Daoping Wang, Dennis Chang, Yinghong Pan, Jianxun Liu · 2018 · PLoS ONE
  92. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma
    Ze Qian, Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, Yacong Wang, Jian Wu, Shusen Zheng · 2019 · Clinics and Research in Hepatology and Gastroenterology
  93. A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients
    Rui Cheng, Lixing Xiao, Wenyang Zhou, Xiyun Jin, Zhaochun Xu, Chang Xu, Pingping Wang, Meng Luo, Mengyun Wang, Kexin Ma et al. · 2021 · Oncogene
  94. Metabolic perturbation, proliferation and reactive oxygen species jointly contribute to cytotoxicity of human breast cancer cell induced by tetrabromo and tetrachloro bisphenol A
    Chao Zhao, Zhi Tang, Arthur C.K. Chung, Hailin Wang, Zongwei Cai · 2018 · Ecotoxicology and Environmental Safety
  95. Sepsis-induced changes in pyruvate metabolism: insights and potential therapeutic approaches
    Louise Nuyttens, Jolien Vandewalle, Claude Libert · 2024 · EMBO Molecular Medicine
  96. The laforin/malin E3-ubiquitin ligase complex ubiquitinates pyruvate kinase M1/M2
    Rosa Viana, Pablo Luján, Pascual Sanz · 2015 · BMC Biochemistry
  97. Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer
    Jiefeng Zhou, Chih-Ming Su, Hsin-An Chen, Shicong Du, Chang‐Wei Li, Haoran Wu, Shin‐Han Tsai, Yu-Ting Yeh · 2020 · OncoTargets and Therapy
  98. Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma
    Hélène Gilgenkrantz, Valérie Paradis, Sophie Lotersztajn · 2023 · Hepatology
  99. Pyruvate Kinase M2 Plays a Dual Role on Regulation of the EGF/EGFR Signaling via E-Cadherin-Dependent Manner in Gastric Cancer Cells
    Leyi Wang, Yunpeng Liu, Ligang Chen, Yanling Chen, Li Tan, Jingjing Liu, Amarsanaa Jazag, Jianlin Ren, Bayasi Guleng · 2013 · PLoS ONE
  100. Metabolic modulation of cancer: a new frontier with great translational potential
    Adam S. Kinnaird, Evangelos D. Michelakis · 2015 · Journal of Molecular Medicine